Skip to Main content Skip to Navigation
Journal articles

Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro

Abstract : Flaviviruses, such as Dengue (DENV) and Zika (ZIKV) viruses, represent a severe health burden. There are currently no FDA-approved treatments, and vaccines against most flaviviruses are still lacking. We have developed several flexible analogues ("fleximers") of the FDA-approved nucleoside Acyclovir that exhibit activity against various RNA viruses, demonstrating their broad-spectrum potential. The current study reports activity against DENV and Yellow Fever Virus (YFV), particularly for compound 1. Studies to elucidate the mechanism of action suggest the flex-analogue triphosphates, especially 1-TP, inhibit DENV and ZIKV methyltransferases, and a secondary, albeit weak, effect on the DENV RNA-dependent RNA polymerase was observed at high concentrations. The results of these studies are reported herein.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03030860
Contributor : Etienne Decroly Connect in order to contact the contributor
Submitted on : Monday, November 30, 2020 - 11:48:25 AM
Last modification on : Wednesday, January 19, 2022 - 4:58:43 PM

Links full text

Identifiers

Collections

Citation

Joy Thames, Charles Waters, Coralie Valle, Marcella Bassetto, Wahiba Aouadi, et al.. Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro. Bioorganic and Medicinal Chemistry Letters, Elsevier, 2020, 28 (22), pp.115713. ⟨10.1016/j.bmc.2020.115713⟩. ⟨hal-03030860⟩

Share

Metrics

Record views

21